Login / Signup

Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma.

Takuya MaedaA HiuraJ UeharaR ToyoshimaT NakagawaK Yoshino
Published in: The British journal of dermatology (2021)
Keyphrases
  • phase ii study
  • ulcerative colitis
  • stem cells
  • clinical trial
  • radiation therapy
  • mesenchymal stem cells
  • cell therapy
  • open label